Diabetic retinopathy and the use of laser photocoagulation: is it cost-effective to treat early?

Keywords

Diabetic retinopathy, Medicine, Willingness to pay, Blindness, Expert opinion

References

• Incidence of sight‐threatening retinopathy in Type 1 diabetes in a systematic screening programmeDominique Stoenesco — 2003
• Responsiveness of the EQ-5D to the Effects of Low Vision Rehabilitation何一萍 — 2013
• Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.Pamela Royle, Hema Mistry, Peter Auguste — 2015
• Rates of Progression in Diabetic Retinopathy During Different Time PeriodsTien Yin Wong, Mkaya Mwamburi, Ronald Klein — 2009
• All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999Sabita S. Soedamah‐Muthu, J. H. Fuller, Henrietta Mulnier — 2006
• Development of the 25-item National Eye Institute Visual Function Questionnaire.Anne L. Coleman — 2001
• Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.Aileen Clarke, Ruth Pulikottil-Jacob, Amy Grove — 2015
• Mortality in people with Type 2 diabetes in the UKHenrietta Mulnier, Helen E. Seaman, Veena Raleigh — 2006
• The Cost of DiabetesKaren Gerard, Cam Donaldson, Alan Maynard — 1989
• Vision loss among diabetics in a group model Health Maintenance Organization (HMO).Donald S. Fong, Mohktar Sharza, Wansu Chen — 2002
• VISUAL SIDE EFFECTS OF SUCCESSFUL SCATTER LASER PHOTOCOAGULATION SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY: A Literature ReviewDonald S. Fong, Aniz Girach, APRIL BONEY — 2007
• Utility values and diabetic retinopathy.Melissa M. Brown, Gary C. Brown, Sanjay Sharma — 1999
• Lower visual acuity predicts worse utility values among patients with type 2 diabetesDavid H. Smith, Eric S. Johnson, Allen Russell — 2008
• Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trialRony Carlos Preti, Lisa Mariel Vasquez Ramirez, Mário Luiz Ribeiro Monteiro — 2013
• Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27.Michael Cusick, Annal D. Meleth, Elvira Agrón — 2005
• The Cost-Effectiveness of Three Screening Alternatives for People with Diabetes with No or Early Diabetic RetinopathyDavid B. Rein, John S. Wittenborn, Xinzhi Zhang — 2011
• Current treatments in diabetic macular oedema: systematic review and meta-analysisJohn Ford, Noemi Lois, Pamela Royle — 2013
• Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trialPaul Mitchell, Lieven Annemans, Meghan Gallagher — 2012
• Global Prevalence and Major Risk Factors of Diabetic RetinopathyJoanne Yau, Sophie Rogers, Ryo Kawasaki — 2012
• Association of ocular disease and mortality in a diabetic population.Ronald Klein — 1999

Cited by

• A multi-spot laser system for retinal disorders treatment: Experimental studyOmnia Hamdy, Sadeq S Alsharafi, Mahmoud Hassan — 2019
• Spermine oxidase: A Promising Therapeutic Target for Neurodegeneration in Diabetic RetinopathyS. Priya Narayanan, Esraa Shosha, Chithra D. Palani — 2019
• Artificial intelligence on diabetic retinopathy diagnosis: an automatic classification method based on grey level co-occurrence matrix and naive Bayesian model.Kai Cao — 2019
• Macular pigment optical density after panretinal photocoagulation.Mustafa Doğan, Bünyamin Kutluksaman — 2020
• Comparing the incidence of major cardiovascular events and severe microvascular complications in patients with type 2 diabetes mellitus: A systematic review and meta-analysisYingying Zhu, Zu‐Yao Yang, Ping Li — 2020
• Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose StudyMahsa Sardarinia, Samaneh Asgari, Reyhane Hizomi Arani — 2021
• Cyanidin-3-o-glucoside (C3G) inhibits vascular leakage regulated by microglial activation in early diabetic retinopathy and neovascularization in advanced diabetic retinopathyFangling Zhao, Xiang Gao, Xiaojuan Ge — 2021
• Update on Management of Non-proliferative Diabetic Retinopathy without Diabetic Macular Edema; Is There a Paradigm Shift?Amir Arabi, Ramin Tadayoni, Hamid Ahmadieh — 2022
• Single-session prophylactic pan-retinal photocoagulation in moderate nonproliferative diabetic retinopathy in low-resource settingsAhmed Mahmoud Fahmy Fathalla, Khaled Abdelazeem, Salma Mohamed Kedwany — 2022
• Management of Nonproliferative Diabetic Retinopathy: Where Do We Stand?Stéphanie Kaiser, Anshul Bhatnagar, Christina Y. Weng — 2023

Related papers

• Prevalence of diabetic retinopathy in Pakistani subjects. A pilot study.A. J. Khan — 1991
• The Various Methods on Early Stage Detection of Diabetic RetinopathyMrutyunjaya, Sarika Raga — 2019
• Clinical Analysis of Ocular Complications in 328 Patients with Diabetes MellitusWang Ying-ka — 2008
• Diabetic retinopathy: newer therapies to prevent blindness.Scott M. Friedman, Melvin L. Rubin — 1992
• Results of 20 years of research on the treatment of diabetic retinopathy.Frederick L. Ferris — 1994
• Short note on Diabetic RetinopathyAkhila Sabbineni — 2020
• Current and investigational drugs for the treatment of diabetic retinopathyMichael Steven Tolentino, Michael Steven Tolentino, Andrew John Tolentino — 2016